PROGYNY, INC. (PGNY): $35.58

-1.50 (-4.05%)

POWR Rating

Component Grades













Filter PGNY News Items

PGNY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

PGNY News Highlights

  • PGNY's 30 day story count now stands at 7.
  • Over the past 21 days, the trend for PGNY's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • BEAT, CSII and EW are the most mentioned tickers in articles about PGNY.

Latest PGNY News From Around the Web

Below are the latest news stories about PROGYNY INC that investors may wish to consider to help them evaluate PGNY as an investment opportunity.

Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?

Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Yahoo | January 30, 2023

Investors in Progyny (NASDAQ:PGNY) have made a return of 27% over the past three years

Progyny, Inc. ( NASDAQ:PGNY ) shareholders might be concerned after seeing the share price drop 23% in the last...

Yahoo | January 30, 2023

Should You Retain Progyny (PGNY) Stock?

Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund delivered 3.46% net of fees compared to a 4.13% return for the Russell 2000 Growth Index. Style factor headwinds and relative sector positioning offset […]

Yahoo | January 25, 2023

Cardiovascular Systems (CSII) Global Sales Up, Margin Woe Stays

Cardiovascular Systems (CSII) international revenues are showing strong growth in each of the key markets, including Japan, Europe, Asia Pacific and Canada.

Yahoo | January 19, 2023

Edwards Lifesciences (EW) Gains From Innovation Amid Cost Woe

Edwards Lifesciences (EW) continues to witness strong momentum of the RESILIA portfolio globally.

Yahoo | January 18, 2023

7 Stocks With a Forward P/E of 25 to Run Away From

Expensive stocks with all the warning signs of having too high a risk of missing expectations are the stocks to avoid.

Chris Lau on InvestorPlace | January 9, 2023

Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference

Anticipates Results to be at the High-End of its Previously Provided Financial GuidanceAnticipates Reporting Record Fourth Quarter Operating Cash Flow of Approximately $50 Million NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that the Company is participating in the 41st Annual JP Morgan Healthcare Conference, where it ex

Yahoo | January 9, 2023

Progyny (NASDAQ:PGNY) Is Doing The Right Things To Multiply Its Share Price

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

Yahoo | January 2, 2023

4 Unstoppable Multibaggers to Buy in 2023 and Hold for the Next Decade

Three-year revenue growth rates between 39% and 54% are projected, making these stocks prime multibagger candidates.

Yahoo | December 27, 2022

ELV vs. PGNY: Which Stock Is the Better Value Option?

ELV vs. PGNY: Which Stock Is the Better Value Option?

Yahoo | December 16, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4864 seconds.